Lin, H.-T.; Cheng, M.-L.; Lo, C.-J.; Lin, G.; Liu, F.-C.
Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry. Diagnostics 2022, 12, 2626.
https://doi.org/10.3390/diagnostics12112626
AMA Style
Lin H-T, Cheng M-L, Lo C-J, Lin G, Liu F-C.
Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry. Diagnostics. 2022; 12(11):2626.
https://doi.org/10.3390/diagnostics12112626
Chicago/Turabian Style
Lin, Huan-Tang, Mei-Ling Cheng, Chi-Jen Lo, Gigin Lin, and Fu-Chao Liu.
2022. "Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry" Diagnostics 12, no. 11: 2626.
https://doi.org/10.3390/diagnostics12112626
APA Style
Lin, H. -T., Cheng, M. -L., Lo, C. -J., Lin, G., & Liu, F. -C.
(2022). Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry. Diagnostics, 12(11), 2626.
https://doi.org/10.3390/diagnostics12112626